Background illustration for clinical trials search

Paid Clinical Trials Scottsdale

Discover 1,293 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

for
Chronic Kidney Disease (Stages 4 and 5), Kidney Disease,
Location: Scottsdale AZ, Phoenix AZ
Sponsor: Well Cell Global

Sex: All

Age: 18+

Code: NCT07187479

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Phoenix AZ, Peoria AZ, Yuma AZ, Imperial CA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: Phoenix AZ, Chandler AZ, Mesa AZ, Peoria AZ, Tucson AZ,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase 3, Recruiting

AVPI Migraine Study

for
Migraine
Location: Scottsdale AZ, Saint Charles MO
Sponsor: Nocira, LLC

Sex: All

Age: 18 - 70+

Code: NCT05537818

Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Phoenix AZ, Scottsdale AZ, Los Angeles CA,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Lysosomal Acid Lipase (LAL) Deficiency Registry

for
Lysosomal Acid Lipase Deficiency,
Location: Phoenix AZ, Stanford CA, Snyder TX, Houston TX,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01633489

Recruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for
Osteoarthritis, Overweight or Obesity
Location: Phoenix AZ, Mesa AZ, Tucson AZ, Spring Valley CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07353931

Phase 3, Recruiting

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

for
Chronic Idiopathic Constipation (CIC)
Location: Phoenix AZ, Chandler AZ, Sun City West AZ, Tucson AZ,
Sponsor: Ardelyx

Sex: All

Age: 18 - 70+

Code: NCT07382167

Phase 3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Phoenix AZ, Tempe AZ, Chandler AZ, Gilbert AZ, Mesa AZ,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase 3, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Phoenix AZ, Scottsdale AZ, Tempe AZ, North Las Vegas NV,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Scottsdale AZ, Chandler AZ, Henderson NV, El Paso TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 65

Code: NCT06752668

Phase 2, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Scottsdale AZ, Phoenix AZ, La Jolla CA, Downey CA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Scottsdale AZ, Phoenix AZ, Gilbert AZ, Las Vegas NV,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Total Shoulder Arthroplasty Multi-Center Registry

for
Shoulder Arthroplasty
Location: Phoenix AZ, Denver CO, Medford OR, Germantown TN,
Sponsor: Arthrex, Inc.

Sex: All

Age: 18 - 70+

Code: NCT03511586

Recruiting

Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

for
Bone Graft; Complications, ACL Injuries
Location: Phoenix AZ, Scottsdale AZ
Sponsor: University of Arizona

Sex: All

Age: 18 - 40

Code: NCT06975306

Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Scottsdale AZ, Tucson AZ, Upland CA, El Paso TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

for
Gastrointestinal Stromal Neoplasms
Location: Scottsdale AZ, San Francisco CA, Houston TX, Omaha NE,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07585266

Phase 3, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Phoenix AZ, Scottsdale AZ, Tempe AZ, Las Vegas NV,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Phase 4, Recruiting

Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial

for
Shoulder Dislocation, Glenohumeral Dislocation,
Location: Tempe AZ, Fort Sam Houston TX, Nashville TN,
Sponsor: University of Pittsburgh

Sex: All

Age: 17 - 50

Code: NCT04809064

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Phoenix AZ, Glendale AZ, Tucson AZ, Gallup NM,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting